Printer Friendly

ARGENTINA MINISTRY OF HEALTH APPROVES DISEASE DETECTION INTERNATIONAL'S SEVEN-MINUTE, WHOLE BLOOD AIDS TEST FOR USE IN NATIONAL PROGRAM

 IRVINE, Calif., Aug. 31 /PRNewswire/ -- Disease Detection International Inc. ("DDI") (OTC Bulletin Board: DDII) announced today that the Argentina Ministry of Health has evaluated and approved the SeroCard(R) HIV-1 test for the antibody to the AIDS virus for use in the National Program for the Flight Against Human Retrovirus and AIDS.
 In a letter dated Aug. 23, 1993, the company was informed that the "Ministerio de Salud Y Accion Social del la Nacion" (Ministry of Health and Social Action of the Nation) has completed its studies of DDI's patented, seven-minute, whole blood AIDS test as submitted, for use in the Argentina National Program for the Fight Against Human Retroviruses and AIDS. The company is now awaiting official documentation which will outline specific instructions on how the test may be supplied to the agency in its national testing programs.
 Argentina's approval is particularly significant due to their National Director for AIDS' aggressive posture and commitment to educational and testing programs for the nation. H. Thad Morris, DDI's president and chief executive officer, stated that "Dr. Miroli, Argentina's Director for AIDS, represents the model and the best example for all nations' health care officials in his tireless efforts to educate and inform the general public of the terrible pandemic of AIDS. Regardless of the test format, in the absence of a cure or vaccination, education and testing represent the world's best hope in slowing down the world's rate of infection. We are pleased to join Dr. Miroli in any way possible to achieve this goal."
 Morris made the Argentina approval announcement in conjunction with the company's announcement of several imminent Latin American distribution agreements. "This approval is significant in light of our progress in signing exclusive distribution agreements in Argentina, Brazil, Columbia, Santo Domingo and Venezuela. Once formalized, and each country has approved our product for import and use, we expect these new business relationships will provide over $1,000,000 in new revenues over the next 12 months and will form the base of our commitment to be a major force in AIDS testing and education in South America."
 In previous announcements, the company has received approval in Mexico to manufacture, market, sell and export the world's first seven- minute, whole blood ELISA test for the antibody to the AIDS virus. In June 1993, DDI also established its first South American joint-venture in Brazil ("DDI do Brasil"), to market, sell and manufacture the SeroCard(R) HIV test. "We have registered our test in Brazil and have commenced sales. It is our hope to begin production in Brazil by the second quarter of 1994, to provide a local manufactured product and even to export to other South American countries."
 Disease Detection International Inc. develops, manufactures and markets a family of patented, rapid diagnostic test kits to aid in the diagnosis of infectious and sexually transmitted diseases. In addition, the company is a major supplier to hospitals, physicians and consumers of its easy-to-use, single-step tests for pregnancy.
 -0- 8/31/93
 /CONTACT: H. Thad Morris, president and CEO of Disease Detection International, 714-457-1787/
 (DDII)


CO: Disease Detection International Inc. ST: California IN: MTC SU:

JB-MF -- LA029 -- 7620 08/31/93 15:56 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 31, 1993
Words:531
Previous Article:SAME STORE SALES UP 46 PERCENT SECOND QUARTER AND EXPANSION CONTINUES
Next Article:SECRETARY PENA PRESENTS $49 MILLION TO MTA FOR RED LINE CONSTRUCTION; $300,000 GRANT TO IMPROVE TRANSIT ACCESSIBILITY FOR NON-ENGLISH SPEAKERS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters